NuGen Medical Devices Inc. (TSXV:NGMD)
Canada
· Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
At close: Mar 9, 2026
NuGen Medical Devices Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 0.59 | 1.01 | 0.33 | 0.15 | 0.14 | 0.05 | Upgrade
|
| Revenue Growth (YoY) | -22.73% | 204.73% | 117.52% | 10.69% | 191.04% | - | Upgrade
|
| Cost of Revenue | 0.27 | 0.49 | 0.17 | 0.05 | 0.05 | 0.01 | Upgrade
|
| Gross Profit | 0.32 | 0.52 | 0.16 | 0.1 | 0.09 | 0.03 | Upgrade
|
| Selling, General & Admin | 3.57 | 5.03 | 7.52 | 4.24 | 5.26 | 2.26 | Upgrade
|
| Operating Expenses | 4.22 | 5.68 | 8.21 | 4.89 | 5.88 | 2.62 | Upgrade
|
| Operating Income | -3.9 | -5.16 | -8.05 | -4.79 | -5.79 | -2.59 | Upgrade
|
| Interest Expense | -2.89 | -1.67 | -1.24 | -1.01 | -1.21 | -0.42 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.11 | -0.11 | -0.11 | -0.1 | 0.3 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.16 | 0.04 | 0.02 | 0.06 | -1.11 | -0.23 | Upgrade
|
| EBT Excluding Unusual Items | -3.74 | -6.89 | -9.38 | -5.84 | -7.81 | -3.38 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.16 | -0.02 | Upgrade
|
| Other Unusual Items | 1.63 | 1.67 | 0.05 | 0.27 | 0.87 | -0.26 | Upgrade
|
| Pretax Income | -2.12 | -5.22 | -9.33 | -5.57 | -7.1 | -3.66 | Upgrade
|
| Income Tax Expense | -0 | 0.01 | 0.03 | 0 | 0 | 0.01 | Upgrade
|
| Net Income | -2.12 | -5.23 | -9.36 | -5.58 | -7.11 | -3.67 | Upgrade
|
| Net Income to Common | -2.12 | -5.23 | -9.36 | -5.58 | -7.11 | -3.67 | Upgrade
|
| Shares Outstanding (Basic) | 225 | 214 | 168 | 90 | 69 | 54 | Upgrade
|
| Shares Outstanding (Diluted) | 225 | 214 | 168 | 90 | 69 | 54 | Upgrade
|
| Shares Change (YoY) | 7.48% | 27.89% | 86.08% | 31.20% | 26.95% | 128.66% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.06 | -0.06 | -0.10 | -0.07 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.06 | -0.06 | -0.10 | -0.07 | Upgrade
|
| Free Cash Flow | -5.51 | -4.72 | -6.72 | -2.13 | -4.1 | -1.4 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.04 | -0.02 | -0.06 | -0.03 | Upgrade
|
| Gross Margin | 54.97% | 51.68% | 49.74% | 65.09% | 67.00% | 72.70% | Upgrade
|
| Operating Margin | -660.85% | -510.70% | -2428.48% | -3146.56% | -4207.91% | -5475.96% | Upgrade
|
| Profit Margin | -359.36% | -517.47% | -2825.03% | -3661.07% | -5163.23% | -7760.65% | Upgrade
|
| Free Cash Flow Margin | -935.58% | -467.79% | -2026.89% | -1399.36% | -2977.84% | -2958.59% | Upgrade
|
| EBITDA | -3.25 | -4.54 | -7.44 | -4.22 | -5.17 | -2.22 | Upgrade
|
| D&A For EBITDA | 0.64 | 0.62 | 0.61 | 0.58 | 0.63 | 0.37 | Upgrade
|
| EBIT | -3.9 | -5.16 | -8.05 | -4.79 | -5.79 | -2.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.